利用药物经济学评价指导药品定价的探讨  

Drug Pricing Guided by Pharmacoeconomic Evaluation

作　　者：李海涛[1] 夏慧[1] 李士保[2] 李士雪[2] 

机构地区：[1]山东大学卫生管理与政策研究中心,卫生部卫生经济与政策研究重点实验室,济南市250012 [2]山东大学公共卫生学院,济南市250012

出　　处：《中国药房》2007年第23期1764-1767,共4页China Pharmacy

摘　　要：目的:探讨如何利用药物经济学评价指导药品定价,以提高药品定价的科学性和合理性。方法:首先指出药物经济学评价在药品定价中所能解决的问题即其应用必要性,然后从全社会的角度出发,对药品的成本和收益进行评估,以对药品的经济性进行评价。结果与结论:药物经济学评价能够用于确定新药的价格范围,指导药品定价,促进药品定价的合理性。OBJECTIVE： To discuss how to apply pharmacoeconomic evaluation in guiding drug pricing so as to make the drug pricing more scientific and reasonable.METHODS： The problems that pharmacoeconomic evaluation can solve in drug pricing, i. e. the necessity of the application of pharmacoeconomic evaluation were pointed out, and the costs and profits of drugs were evaluated pharmacoeconomically from the perspective of the whole society.RESULTS ＆ CONCLUSION： Pharmacoeconomic evaluation can be utilized to determine the price rartges of new drugs, guide drug pricing and enhance the rationality of drug pricing.

关 键 词：药物经济学 评价 药品 定价 

分 类 号：R956[医药卫生—药学]